Scott M. Rocklage, a Founding Partner at 5AM Ventures, invests primarily in early-stage biotech and digital health. See sector focus and contact routes.
Scott M. Rocklage, a Founding Partner at 5AM Ventures, invests primarily in early-stage biotech and digital health companies at the Seed and Series A levels, focusing on breakthrough scientific innovations with strong commercial potential. His notable portfolio includes Nouscom, Expansion Therapeutics, Achaogen, NodThera, and Pulmatrix, with Rocklage serving as board chairman or member for several of these firms. His distinctive thesis emphasizes translating transformative biology and technology into therapies that meaningfully improve patient outcomes, leveraging his three decades of healthcare management experience and FDA drug approval leadership.
Details on this investor come from filing and round data held in the StartupFundraising directory, refreshed on ingest. Founders use profiles like this one to qualify fit and to shortlist investors in Palm Beach Gardens.
Investors like Scott M. Rocklage · Full investor directory · Investor access · Company funding database